Cite

HARVARD Citation

    Eskazan, A. (2019). Is measuring plasma imatinib trough levels still an appropriate way for predicting responses in patients with chronic myeloid leukemia?. Leukemia & lymphoma. 60 (8), pp. 2094-2095. [Online]. 
  
Back to record